Navigate Canada's pharmaceutical and medical device regulatory landscape with confidence. MedWisdom provides end-to-end dossier preparation, Health Canada submissions, clinical trial support, and post-market compliance — so you can achieve market authorization faster.
Years of Regulatory Expertise
Successful Global Submissions
Countries Served
Compliance-First Approach
Canada ranks among the world's top ten pharmaceutical markets, offering a stable economic environment, transparent regulatory processes, and strong demand for innovative healthcare products. With a rigorous yet predictable approval framework, it presents significant long-term commercial opportunities for both multinational corporations and emerging manufacturers.
Health Canada, through its Health Products and Food Branch (HPFB), oversees the regulation of drugs, biologics, natural health products, and medical devices. All products entering the Canadian market must obtain pre-market authorization before commercialization — and compliance with post-market obligations is equally critical for sustained market presence.
Key authorization pathways MedWisdom supports include:
| Application Type | Product Category | Typical Timeline |
|---|---|---|
| NDS (New Drug Submission) | Innovator Drugs | 12–24 months |
| ANDS (Abbreviated NDS) | Generic Drugs | 12–18 months |
| SNDS (Supplemental) | Post-Approval Changes | 6–12 months |
| CTA / CTA-A | Clinical Trials | 30 days (default) |
| Medical Device Licence | Class II / III / IV | 15 days – 300 days |
| NHP Product Licence | Natural Health Products | 60–300 days |
| MDEL | Device Importers/Distributors | ~30 days |
From initial product classification and dossier strategy to submission and post-market surveillance, MedWisdom provides full-spectrum regulatory support for the Canadian market.
Preparation of complete Common Technical Document (CTD) and electronic CTD (eCTD) dossiers compliant with Health Canada's submission standards. We ensure all modules — administrative, quality, non-clinical, and clinical — are structured, cross-referenced, and technically sound.
Learn More →End-to-end preparation and submission of Clinical Trial Applications to Health Canada, including IND-equivalent documentation, protocol review, Investigator's Brochure (IB) preparation, ethics coordination, and regulatory follow-up to achieve a No Objection Letter (NOL).
Enquire Now →Comprehensive support for Medical Device Establishment Licences (MDEL), Class II, III, and IV device licence applications, Quality Management System (QMS/ISO 13485) documentation, and compliance with Canada's Medical Devices Regulations (SOR/98-282).
Learn More →Implementation of robust post-market surveillance (PMS) programs, mandatory problem reporting (MPR) to Health Canada, Medical Device Vigilance reporting, risk management planning, trend analysis, and ongoing compliance with Canada's post-approval obligations.
Learn More →Assistance in obtaining Establishment Licences (EL) for drug manufacturers, importers, and packagers; MDEL for medical device importers and distributors; batch release documentation; and full compliance with Health Canada's importation and exportation requirements under the Food and Drugs Act.
Enquire Now →Review and pre-approval preparation of all advertising content and promotional claims to ensure conformity with Health Canada's Food and Drugs Act, Pharmaceutical Advertising Advisory Board (PAAB) guidelines, and Ad Standards of Canada — protecting you from enforcement risk.
Enquire Now →Expert preparation and facilitation of Health Canada pre-submission meetings, Type A/B/C meetings, and scientific advice interactions. We draft briefing documents, formulate queries, and act as direct liaisons with Health Canada reviewers to resolve issues and accelerate approvals.
Book a Consultation →Strategic management of Supplemental New Drug Submissions (SNDS), Notifiable Changes (NC), and Annual Notifications to Health Canada. We identify the appropriate change level, prepare the required documentation, and manage timelines to minimize disruption to your supply chain.
Learn More →Full regulatory support for Natural Health Products, including site licence and product licence applications, evidence assessment, labelling compliance under the Natural Health Products Regulations (NHPR), and responses to Health Canada queries for efficient NOC/Product Number issuance.
Enquire Now →A structured, milestone-driven process that reduces delays, avoids deficiencies, and ensures compliance at every step.
We analyze your product, identify the correct regulatory pathway, and define the submission strategy aligned with Health Canada requirements.
A detailed gap analysis identifies missing data, documentation deficiencies, and study requirements before submission preparation begins.
Our experts compile, structure, and quality-review the complete CTD/eCTD dossier against Health Canada's published standards and guidance documents.
We manage the electronic submission, respond to Clarifax/Screening Deficiency Notices (SDN), and liaise directly with Health Canada reviewers throughout the review.
Post-approval, we support ongoing pharmacovigilance, labelling updates, post-market studies, and variation submissions to maintain your market authorization.
Answers to the most common questions we receive from pharmaceutical and medical device companies entering the Canadian market.
Preparation and submission of Clinical Trial Applications (CTA/CTA-A) to Health Canada, including IND-equivalent support, protocol review, and regulatory follow-up.
Implementation of PMS plans, mandatory problem reporting (MPR), recall management, trend analysis, and ongoing compliance with Health Canada post-market obligations for drugs and devices.
Support for obtaining import/export licences, establishment licences (MDEL for devices), batch release documentation, and compliance with Health Canada importation/exportation requirements.
Review and approval preparation of advertising, promotional claims, and materials to ensure compliance with Health Canada’s Food and Drugs Act, PAAB, and Ad Standards guidelines.
Preparation and facilitation of Health Canada meetings (Pre-Submission, Type A/B/C, scientific advice), query responses, and direct liaison with reviewers for efficient approvals.
Partner with Medwisdom for expert, streamlined, and fully compliant regulatory support in Canada - from Health Canada submissions and product classification to clinical trials, post-market surveillance, and long-term market success.
Contact Our Canada Regulatory Experts